Relcovaptan

Relcovaptan
	220px
Systematic (IUPAC) name
	1-({(2R,3S)-5-chloro-3-(2-chlorophenyl)-1-[(3,4-dimethoxyphenyl)sulfonyl]-3-hydroxy-2,3-dihydro-1H-indol-2-yl}carbonyl)-L-prolinamide
Identifiers
CAS Number	150375-75-0
ATC code	none
PubChem	CID 60943
Synonyms	(2S)-1-[(2R,3S)-5-chloro-3-(2-chlorophenyl)-1-(3,4-dimethoxyphenyl)sulfonyl-3-hydroxy-2H-indole-2-carbonyl]pyrrolidine-2-carboxamide
Chemical data
Formula	C28H27Cl2N3O7S
Molar mass	620.501[[Script error: No such module "String".]]
	Script error: No such module "collapsible list".

Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

Relcovaptan (SR-49059) is a non-peptide inhibitor of the antidiuretic hormone (vasopressin) receptor, selective for the V1a subtype.^[1] It has shown positive initial results in tests against Raynaud's disease, dysmenorrhoea, and tocolysis,^[2] although it is not yet approved for clinical use.

References

Cite error: Invalid <references> tag; parameter "group" is allowed only.

Use <references />, or <references group="..." />

45px	This hormonal preparation article is a stub. You can help ssf by expanding it. v d e

↑ Lemmens-Gruber R, Kamyar M. Vasopressin antagonists. Cellular and Molecular Life Sciences. 2006 Aug;63(15):1766-79. PMID 16794787
↑ Decaux G, Soupart A, Vassart G. Non-peptide arginine-vasopressin antagonists: the vaptans. Lancet. 2008 May 10;371(9624):1624-32. PMID 18468546